ASBrS 2024 Exact Sciences Product Theater Registration |
- Please join us for our Product Theater on Wednesday, April 10 at 7:00pm - 8:30pm ET at the Orlando World Center Marriott).
Title: Unlocking Tomorrow's Care: The Power of Germline, Oncotype DX, and Molecular Residual Disease (MRD) Testing in Shaping Personalized Breast Cancer Care
Speakers:
Katharine A. Yao, MS, MD
Vice Chair of Research, department of Surgery
Director, Breast Cancer Research Program
Program Director, Surgical Outcomes Research, Outcomes Research Network
NorthShore University Health System
Marla Lipsyc-Sharf, MD
Health Sciences Clinical Instructor of Medicine
Translational Oncology Research Laboratory of the Jonsson Comprehensive Cancer Center
University of California – Los Angeles
Jennifer Racz, MD
Director, Medical Affairs, Oncology
Exact Sciences
Learning Objectives:
- Recognize the expanded use of the Oncotype DX Breast Recurrence Score® test for decision-making in the adjuvant setting beyond systemic therapy
- Explore the rationale behind the recent ASCO recommendation for germline testing in breast cancer patients.
- Discuss the evolving role of molecular residual disease (MRD) testing in breast cancer patients.